MAPT and Alzheimer disease: This could be due to the fact that while total tau, NfL and TNF-α are used as biomarkers for AD, they are also non-specific to AD and can be indicative of other conditions [20–22], whereas biomarkers such as Aβ42/Aβ40 and p-tau are more closely associated with AD-dementia [23].